Vertican Growth.Inc announces the acquisition of 100% of the outstanding shares of three companies called Algamur SA, Wemblar Corporation SA, Dukiliu Trade SA based in Uruguay which main objectives are cultivation, extraction and develop of pharmaceutical grade products derived from cannabis.

These three companies will develop and structure in accordance with the regulations of the Uruguayan authorities. (IRCCA: Instituto de Regulación y Control del Cannabis https://www.ircca.gub.uy/licencias-aprobadas/). All the necessary means for cultivation, medical range conception and distribution are based in Uruguay.

The Company’s subsidiaries were granted licenses in February 2020 both for the cultivation of cannabis and for the extraction of the main compounds (mainly THC and CBD).

Vertican Growth, Inc is launching a vertically integrated project by its sub companies called Algamur S.A, which will grow flowers with high CBD and THC content, Wemblar Corporation S.A, which will follow with the extraction process of the compounds of interest and Dukilu Trade S.A which will develop pharmaceutical products for pharma and cosmetics industry.    

Vertican Growth Inc, Founder Miguel Loinaz commented: “We are happy to be part of a promising sector such as Medical Cannabis and we have full confidence in the advantages that Uruguay brings us as a country in which to base our operations thanks to its political, economic legal stability and strategic geolocation. ”

Vertican Growth Inc, contact:

Web: www.verticangrowth.com

Contact name: Miguel Loinaz D´Isabella

Contact email:  pr@verticangrowth.com 

Phone number:  +1 647-805-2953

Legal warning

Forward-Looking Statements Certain statements contained in this news release constitute forward-looking statements or forwardlooking information under applicable securities legislation. Forward-looking statements include all disclosures regarding possible events, conditions or results of operations that are based on assumptions about future economic conditions and courses of action. Forward-looking statements may also include, without limitation, any statement relating to future events, conditions or circumstances. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. Often, but not always, forward-looking statements can be identified by the use of words or phrases such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, “believes” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, and may be based on management’s current assumptions and expectations related to all aspects of the Company’s business, industry and the global economy. Further, the Company cautions that this foregoing list of material factors is not exhaustive and additional information identifying risks are detailed from time to time in the Company’s other continuous disclosure filings. The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.